Book of the Week: Lifespan by David Sinclair
Harvard geneticist David Sinclair argues that aging is a disease — and that we already have the tools to slow, stop, and potentially reverse it. Here's the core thesis and what it means for how you live.
Lifespan: Why We Age — and Why We Don't Have To by David A. Sinclair, PhD with Matthew LaPlante (2019)
If you've spent any time in longevity circles, you've encountered David Sinclair's name. A professor at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research, Sinclair has spent three decades studying the molecular biology of aging. Lifespan is his attempt to synthesize that research into an accessible argument for a radical idea: aging is not an inevitable fact of life — it's a disease, and it can be treated.
The Core Thesis: The Information Theory of Aging
Sinclair's central framework is what he calls the Information Theory of Aging. He proposes that aging is primarily caused by the loss of epigenetic information — not mutations to DNA itself, but the gradual degradation of the cellular machinery that reads and expresses DNA correctly.
Think of DNA as the master hard drive of your cells. The epigenome is the software that determines which genes are read, in which cells, at which times. Over decades, "epigenetic noise" accumulates — the result of cell division, environmental insults, and the ongoing demands of DNA repair. Cells begin to lose their identity, forgetting what type of cell they're supposed to be. Sinclair argues this loss of cellular identity is the primary driver of the aging phenotype: inflammation, tissue dysfunction, organ decline.
The good news, according to Sinclair: information can be restored. The analogy he uses is a scratched CD — the data is still there, it just needs to be read properly again.
Key Frameworks and Concepts
The Longevity Genes: Sinclair's early research focused on sirtuins — a family of proteins that regulate cellular health, DNA repair, and stress responses. Sirtuins are activated by caloric restriction, exercise, and certain molecules. When sirtuins are busy repairing DNA damage, they neglect their gene-expression roles, contributing to aging. This competition for sirtuin attention is central to his model.
NAD+ and its Decline: Sirtuins require NAD+ (nicotinamide adenine dinucleotide) as a cofactor. NAD+ levels decline with age, limiting sirtuin activity. Sinclair is a proponent of NMN and NR supplementation to restore NAD+ levels — a topic that has since spawned significant research and debate.
mTOR and AMPK: Sinclair frames longevity signaling around three key pathways — sirtuins, mTOR (which drives growth and is suppressed by rapamycin and fasting), and AMPK (which senses low energy and activates protective responses). Activating longevity pathways generally means periodically stressing the system: fasting, exercise, cold, heat.
Xenohormesis: The idea that plants produce stress-response compounds (polyphenols like resveratrol) when under environmental stress — and that consuming those compounds activates our own stress-response pathways. This is Sinclair's rationale for resveratrol and related molecules.
Who It's For
Lifespan is written for a general audience but doesn't talk down to readers. It's best suited for anyone curious about the cutting edge of aging science and willing to sit with some intellectual uncertainty — Sinclair is explicit that he's discussing an evolving field, not settled consensus. Biohackers, health-optimizers, and anyone who has lost loved ones to age-related disease will find it compelling and, at times, genuinely moving.
Be aware: some of Sinclair's claims — particularly around resveratrol and NMN — have been contested by other researchers. The book reflects his lab's perspective, not universal scientific agreement. Read it as a well-argued hypothesis, not a verdict.
Key Takeaway
Sinclair's most actionable argument isn't about a specific supplement — it's a mindset shift. Aging has been treated as background noise, an inevitability to be managed rather than a problem to be solved. Lifespan makes the case that treating aging as a disease worthy of serious intervention could be the most important medical reorientation of our time. Whether or not every detail holds up, the question it asks — why should we accept aging? — is one worth sitting with.
Best for: Anyone interested in longevity science, biohacking, and the biology of aging who wants to understand the theoretical foundations behind many popular supplements and protocols.